These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 27840032)

  • 1. Hepatitis C virus and atherosclerosis: A legacy after virologic cure?
    Bassendine MF; Nielsen SU; Bridge SH; Felmlee DJ; Sheridan DA; Packard CJ; Neely RD
    Clin Res Hepatol Gastroenterol; 2017 Feb; 41(1):25-30. PubMed ID: 27840032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibody to apolipoprotein A-1 in hepatitis C virus infection: a role in atherosclerosis?
    Bridge SH; Pagano S; Jones M; Foster GR; Neely D; Vuilleumier N; Bassendine MF
    Hepatol Int; 2018 Jan; 12(1):17-25. PubMed ID: 29423541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is hepatitis C associated with atherosclerotic burden? A systematic review and meta-analysis.
    Huang H; Kang R; Zhao Z
    PLoS One; 2014; 9(9):e106376. PubMed ID: 25184517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Very low-density lipoprotein/lipo-viro particles reverse lipoprotein lipase-mediated inhibition of hepatitis C virus infection via apolipoprotein C-III.
    Sun HY; Lin CC; Lee JC; Wang SW; Cheng PN; Wu IC; Chang TT; Lai MD; Shieh DB; Young KC
    Gut; 2013 Aug; 62(8):1193-203. PubMed ID: 22689516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Both hepatitis C virus and Chlamydia pneumoniae infection are related to the progression of carotid atherosclerosis in patients undergoing lipid lowering therapy.
    Sawayama Y; Okada K; Maeda S; Ohnishi H; Furusyo N; Hayashi J
    Fukuoka Igaku Zasshi; 2006 Aug; 97(8):245-55. PubMed ID: 17087362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of hepatitis C virus in patients with terminal renal disease undergoing dialysis in southern Brazil: prevalence, risk factors, genotypes, and viral load dynamics in hemodialysis patients.
    Vidales-Braz BM; da Silva NM; Lobato R; Germano FN; da Mota LD; Barros EJ; de Martinez AM
    Virol J; 2015 Feb; 12():8. PubMed ID: 25644891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin's lymphoma: a multicenter Italian experience.
    Vallisa D; Bernuzzi P; Arcaini L; Sacchi S; Callea V; Marasca R; Lazzaro A; Trabacchi E; Anselmi E; Arcari AL; Moroni C; Bertè R; Lazzarino M; Cavanna L
    J Clin Oncol; 2005 Jan; 23(3):468-73. PubMed ID: 15659492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection.
    Hsu CS; Liu CH; Liu CJ; Wang CC; Chen CL; Lai MY; Chen PJ; Chen DS; Kao JH
    Am J Gastroenterol; 2009 Mar; 104(3):598-604. PubMed ID: 19262519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral regimen complexity index as an independent predictor of sustained virologic response in patients with chronic hepatitis C.
    Galán RJ; Cidoncha EC; Martin MF; Rodriguez CC; Almeida CV; Verdugo RM
    J Manag Care Pharm; 2013; 19(6):448-53. PubMed ID: 23806058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory status in human hepatic cirrhosis.
    Martínez-Esparza M; Tristán-Manzano M; Ruiz-Alcaraz AJ; García-Peñarrubia P
    World J Gastroenterol; 2015 Nov; 21(41):11522-41. PubMed ID: 26556984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High plasma level of nucleocapsid-free envelope glycoprotein-positive lipoproteins in hepatitis C patients.
    Scholtes C; Ramière C; Rainteau D; Perrin-Cocon L; Wolf C; Humbert L; Carreras M; Guironnet-Paquet A; Zoulim F; Bartenschlager R; Lotteau V; André P; Diaz O
    Hepatology; 2012 Jul; 56(1):39-48. PubMed ID: 22290760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus infection and cryoglobulinaemia.
    Lunel F; Musset L
    Forum (Genova); 1998; 8(1):95-103. PubMed ID: 9514994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmitted/Founder Viruses Rapidly Escape from CD8+ T Cell Responses in Acute Hepatitis C Virus Infection.
    Bull RA; Leung P; Gaudieri S; Deshpande P; Cameron B; Walker M; Chopra A; Lloyd AR; Luciani F
    J Virol; 2015 May; 89(10):5478-90. PubMed ID: 25740982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of HCV infection on insulin-like growth factor 1 and proinflammatory cytokines: association with risk for growth hormone resistance development.
    Helaly GF; El-Afandy NM
    Egypt J Immunol; 2009; 16(2):115-24. PubMed ID: 22059359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015.
    Monaco S; Mariotto S; Ferrari S; Calabrese M; Zanusso G; Gajofatto A; Sansonno D; Dammacco F
    World J Gastroenterol; 2015 Nov; 21(42):11974-83. PubMed ID: 26576086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma.
    Leone N; Rizzetto M
    Minerva Gastroenterol Dietol; 2005 Mar; 51(1):31-46. PubMed ID: 15756144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of association of hepatitis C virus load and genotype with risk of end-stage liver disease in patients with human immunodeficiency virus coinfection.
    Goedert JJ; Hatzakis A; Sherman KE; Eyster ME;
    J Infect Dis; 2001 Nov; 184(9):1202-5. PubMed ID: 11598846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C (HCV) genotype and viral titer distribution among Argentinean hemophilic patients in the presence or absence of human immunodeficiency virus (HIV) co-infection.
    Picchio GR; Nakatsuno M; Boggiano C; Sabbe R; Corti M; Daruich J; Pérez-Bianco R; Tezanos-Pinto M; Kokka R; Wilber J; Mosier D
    J Med Virol; 1997 Jun; 52(2):219-25. PubMed ID: 9179772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vertically acquired hepatitis C virus infection: Correlates of transmission and disease progression.
    Tovo PA; Calitri C; Scolfaro C; Gabiano C; Garazzino S
    World J Gastroenterol; 2016 Jan; 22(4):1382-92. PubMed ID: 26819507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin resistance as a predictor of early virologic response to HCV therapy among chronic HCV Egyptian patients.
    Abd El-Wahab EW; Mikheal A; Sidkey F; Shatat HZ
    J Med Virol; 2015 Mar; 87(3):428-40. PubMed ID: 25583244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.